Search results
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
1 year ago
ACC 2025 - EVOLUT Low-Risk findings show the Medtronic TAVR system is a safe and effective treatment for aortic stenosis vs surgical valves at five years.Dr Michael Reardon (Houston Methodist, Texas, US) joins us onsite at ACC to discuss the EVOLUT Low Risk trial (NCT02701283; Medtronic Cardiovascular), investigating the safety and effectiveness of the Medtronic TAVR system compared to surgical…
View more
Added:
3 months ago
Source:
Transcatheter Academy
Seven-year follow-up data from the PARTNER 3 trial shows no significant difference in key outcomes between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This long-term assessment provides further insight into valve durability and clinical outcomes, building on previous 5-year data which…
View more
Added:
7 months ago
Source:
Radcliffe Cardiology
Long-term data from the PARTNER 3 trial show no significant differences in key clinical outcomes at 7 years between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This extended follow-up provides crucial insights into the durability and long-term safety of both procedures in this patient…
View more
Added:
9 months ago
The ESC Congress 2025 symposium, “Transforming the Care of Female and Low-Risk Younger Patients With Aortic Stenosis Through Guidelines” is now available on demand.Chaired by Prof Stephan Windecker (Bern University Hospital, Bern, Switzerland) and Prof Vijay Kunadian (Newcastle University, Newcastle-upon-Tyne, UK), this session explores evolving strategies to optimise care for women and younger…
View more
Added:
2 years ago
EuroPCR 24 - We are joined onsite by Prof Ole De Backer (Rigshospitalet, DK) to discuss the findings from the NOTION-2 Study. (NCT02825134).NOTION-2 is a randomized, multicenter trial which aimed to investigate transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in 376 patients under 75 years of age with severe aortic valve stenosis in regard to intra-…
View more
Added:
9 months ago
Source:
Transcatheter Academy
A large-scale meta-analysis suggests that for patients with severe symptomatic aortic stenosis (AS) at a low- to intermediate-surgical risk, transcatheter aortic valve implantation (TAVI) is associated with a lower risk of all-cause death or any stroke at one year compared with surgical aortic valve replacement (SAVR).¹This study was an individual participant data (IPD) meta-analysis of four…
View more
Added:
7 months ago
Dr Matthias Götberg (Skane University Hospital, SE), Dr Karim Al-Azizi (Baylor Scott & White Legacy Heart Center, US) and Prof Farrel Hellig (Sunninghill Hospital, ZA) delve into the evolving field of ultra-low contrast PCI. The faculty explore how interventional cardiologists can achieve procedural precision while significantly reducing contrast usage.Through a combination of expert…
View more
Start date:
Oct 30, 2025
Join Dr Matthias Götberg (Skane University Hospital, SE), Dr Karim Al-Azizi (Baylor Scott & White Legacy Heart Center, US) and Prof Farrel Hellig (Sunninghill Hospital, ZA) in this webinar as they delve into the evolving field of ultra-low contrast PCI. The faculty will explore how interventional cardiologists can achieve procedural precision while significantly reducing contrast usage.Through a…
View more
Interventional Treatment of IHR-PE
Added:
1 year ago
Review Article